Strategic Clinical Network MEDSIR operates an international network of oncology investigators and engages with pharma companies, biotechs, and public institutions to design and manage investigator-initiated trials, presenting a partnership opportunity for sponsors seeking efficient, investigator-led studies.

Recent High-Profile Engagements Active participation and presentations at ASCO 2026, ESMO Breast 2026, SCOPE Summit 2026, SABCS 2025, and WCLC 2025, including collaboration results with Roche, indicate strong visibility and credibility in oncology research—prospects can leverage MEDSIR for co-development and publication-ready trial outcomes.

Clinical Trial Focus Specialization in oncology trial design from concept to publication, with a track record of advancing diverse approaches across multiple tumor types, offering sponsors a streamlined path from idea to actionable results.

Collaborations and AI Recent partnerships with Ataraxis AI and demonstrated use of AI-powered predictive tools in breast cancer trials suggest opportunities for sponsors to integrate advanced analytics and digital health solutions into trial design and execution.

Financial and Scale Up Revenue range indicates a mid-market player capable of handling mid- to large-scale investigator-led programs; potential sponsors from mid-cap to large pharma seeking flexible, focused oncology trial management without the overhead of larger CROs.